195 related articles for article (PubMed ID: 32764529)
1. Two Reliable Methodical Approaches for Non-Invasive
Bohmova J; Lubusky M; Holuskova I; Studnickova M; Kratochvilova R; Krejcirikova E; Durdova V; Kratochvilova T; Dusek L; Prochazka M; Vodicka R
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764529
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
3. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
4. Screening of RHD fetal genotype in RhD negative women.
Kratochvílová T; Böhmová J; Durdová V; Vodička R; Holusková I; Langová K; Lubušký M
Ceska Gynekol; 2020; 85(3):156-163. PubMed ID: 33562966
[TBL] [Abstract][Full Text] [Related]
5. Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran.
Ahmadi MH; Hantuoshzadeh S; Okhovat MA; Nasiri N; Azarkeivan A; Amirizadeh N
Indian J Hematol Blood Transfus; 2016 Dec; 32(4):447-453. PubMed ID: 27812255
[TBL] [Abstract][Full Text] [Related]
6. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving.
Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM
Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy.
Isakson P; Pardi C
Blood Transfus; 2023 Nov; 21(6):472-478. PubMed ID: 36795345
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
[TBL] [Abstract][Full Text] [Related]
9. [RHD genotyping from cell-free fetal DNA circulating in pregnant women peripheral blood and sensitivity assessment of innovated diagnostic approaches for introduction into the clinical practice].
Böhmová J; Vodička R; Lubušký M; Studničková M; Holusková I; Vrtěl R; Kratochvílová R; Frydrychová M; Krejčiříková E; Filipová H
Ceska Gynekol; 2013 Jan; 78(1):32-40. PubMed ID: 23607381
[TBL] [Abstract][Full Text] [Related]
10. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population.
Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML
Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
Clausen FB; Barrett AN;
Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA.
Gönenç G; Işçi H; Yiğiter AB; Hançer V; Büyükdoğan M; Güdücü N; Dünder I
Clin Exp Obstet Gynecol; 2015; 42(3):344-6. PubMed ID: 26152007
[TBL] [Abstract][Full Text] [Related]
15. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
[TBL] [Abstract][Full Text] [Related]
16. Optimization of diagnostic strategy for non-invasive cell-free foetal RHD determination from maternal plasma.
Pazourkova E; Zednikova I; Korabecna M; Kralova J; Pisacka M; Novotna M; Calda P; Horinek A
Vox Sang; 2021 Oct; 116(9):1012-1019. PubMed ID: 33761162
[TBL] [Abstract][Full Text] [Related]
17. Detection of fetal RhD gene from maternal blood.
Günel T; Kalelioğlu I; Ermiş H; Aydınlı K
J Turk Ger Gynecol Assoc; 2010; 11(2):82-5. PubMed ID: 24591904
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
[TBL] [Abstract][Full Text] [Related]
19. Risk Minimization of Hemolytic Disease of the Fetus and Newborn Using Droplet Digital PCR Method for Accurate Fetal Genotype Assessment of
Vodicka R; Bohmova J; Holuskova I; Krejcirikova E; Prochazka M; Vrtel R
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925253
[TBL] [Abstract][Full Text] [Related]
20. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
